Cargando…

Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients

BACKGROUND: No study has compared the long-term prognoses of hepatitis C patients with hepatitis C virus (HCV) antibody-negative individuals and investigated the effects of interferon (IFN) treatment. To clarify the long-term prognosis of HCV-positive residents of an isolated Japanese island and pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamasaki, Kazumi, Tomohiro, Mayumi, Nagao, Yumiko, Sata, Michio, Shimoda, Toshiaki, Hirase, Kazuhiro, Shirahama, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502559/ https://www.ncbi.nlm.nih.gov/pubmed/23057417 http://dx.doi.org/10.1186/1471-230X-12-139

Ejemplares similares

Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study
por: Nagao, Yumiko, et al.
Publicado: (2012)

Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals
por: Nagao, Yumiko, et al.
Publicado: (2016)

Analysis of the factors motivating HCV-infected patients to accept interferon therapy
por: Nagao, Yumiko, et al.
Publicado: (2012)

Dental problems delaying the initiation of interferon therapy for HCV-infected patients
por: Nagao, Yumiko, et al.
Publicado: (2010)

A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus
por: Nagao, Yumiko, et al.
Publicado: (2012)

Disappearance of Oral Lichen Planus After Liver Transplantation for Primary Biliary Cirrhosis and Immunosuppressive Therapy in a 63-year-Old Japanese Woman
por: Nagao, Yumiko, et al.
Publicado: (2014)

Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases
por: Nagao, Yumiko, et al.
Publicado: (2012)

Effect of Oral Care Gel for Burning Mouth Syndrome in a Patient with Hepatitis C: A Case Report
por: Nagao, Yumiko, et al.
Publicado: (2017)

Use of Direct-Acting Antivirals for the Treatment of Hepatitis C Virus-Associated Oral Lichen Planus: A Case Report
por: Misaka, Kenji, et al.
Publicado: (2016)

Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan
por: Nagao, Yumiko, et al.
Publicado: (2010)

Effect of oral care gel on the quality of life for oral lichen planus in patients with chronic HCV infection
por: Nagao, Yumiko, et al.
Publicado: (2011)

Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
por: Nagao, Yumiko, et al.
Publicado: (2014)

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma
por: Nagao, Yumiko, et al.
Publicado: (2017)

Education and Awareness Activities Regarding Hepatitis B and C Among Japanese Dental Health Workers in the Oita Prefecture
por: Nagao, Yumiko, et al.
Publicado: (2022)

Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia
por: Kawaguchi, Takumi, et al.
Publicado: (2019)

Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C
por: Moritou, Yuki, et al.
Publicado: (2013)

Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment
por: Hashimoto, Satoru, et al.
Publicado: (2016)

Analysis of hepatitis B and C virus infections amongst members of the Dental National Health Insurance Society in the Oita Prefecture
por: Nagao, Yumiko, et al.
Publicado: (2021)

Mediastinal T-cell Lymphoblastic Lymphoma Diagnosed with a Skin Biopsy
por: Chiba, Yosuke, et al.
Publicado: (2020)

Association of STAT4 Polymorphisms with Susceptibility to Type-1 Autoimmune Hepatitis in the Japanese Population
por: Migita, Kiyoshi, et al.
Publicado: (2013)

Effects of Hepatitis C Virus Elimination by Direct-Acting Antiviral Agents on the Occurrence of Oral Lichen Planus and Periodontal Pathogen Load: A Preliminary Report
por: Nagao, Yumiko, et al.
Publicado: (2021)

Onset of Oral Lichen Planus Led to Direct-Acting Antiviral Therapy in a Patient with Long-Term Hepatitis C: The Role of a Dentist as Gatekeeper
por: Nagao, Yumiko, et al.
Publicado: (2023)

Psoriasis and Hepatitis C: Improvement with Interferon
por: Habte-Gabr, Eyassu, et al.
Publicado: (2011)

Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir
por: Tamai, Hideyuki, et al.
Publicado: (2017)

Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
por: Yoshida, Takafumi, et al.
Publicado: (2002)

Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient
por: Kawaguchi, Takumi, et al.
Publicado: (2012)

Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
por: Yada, Masayoshi, et al.
Publicado: (2018)

Novel Biomarkers Associated With the Outcome of Interferon-Based Hepatitis C Virus Therapy
por: von Schaewen, Markus, et al.
Publicado: (2015)

An Analysis of Risk Factors for Developing Hepatocellular Carcinoma in a Group of Hepatitis C Patients with Stage 3 Fibrosis following Interferon Therapy
por: Mahmood, Sabina, et al.
Publicado: (2008)

Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study
por: Kawano, Akira, et al.
Publicado: (2018)

Detection of MAGE‐4 Protein in the Sera of Patients with Hepatitis‐C Virus‐associated Hepatocellular Carcinoma and Liver Cirrhosis
por: Tsuzurahara, Shin‐ichi, et al.
Publicado: (1997)

Response Guided Interferon Therapy for Genotype 3 of Chronic Hepatitis C: Compliance and Outcome
por: Sarwar, Shahid, et al.
Publicado: (2015)

Hepatitis C Virus Infection Suppresses the Interferon Response in the Liver of the Human Hepatocyte Chimeric Mouse
por: Tsuge, Masataka, et al.
Publicado: (2011)

Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus
por: Miyaki, Eisuke, et al.
Publicado: (2017)

The CFTR gene variants in Japanese children with idiopathic pancreatitis
por: Iso, Manami, et al.
Publicado: (2019)

The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers
por: Tanabe, Masaki, et al.
Publicado: (2017)

Hyercalcemia induced by interferon therapy in chronic hepatitis C
por: Albaker, Waleed I.
Publicado: (2012)

Evolution of Interferon-Based Therapy for Chronic Hepatitis C
por: Chen, Chun-Hao, et al.
Publicado: (2010)

Review of consensus interferon in the treatment of chronic hepatitis C
por: Witthöft, Th
Publicado: (2008)

Type III Interferons in Hepatitis C Virus Infection
por: Boisvert, Maude, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5jhut1dhbnl3e9h0m9jfnu8e1n